VR Logo

Harvard Bioscience Inc. (HBIO) download report


Healthcare | Medical Devices & Equipment

Harvard Bioscience Inc. (HBIO) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally.

IPO Date: 07-Dec-2000

Pres, CEO & Chairman: Mr. James W. Green

Chief Financial Officer: Mr. Michael A. Rossi

Listing: NASDAQ: HBIO

Country: United States

Headquarters: Holliston, MA

Website: https://www.harvardbioscience.com

Key Facts

Market cap: $152.59 Mln

Revenue (TTM): $120.69 Mln

Earnings (TTM): $-6.50 Mln

Cash: $5.43 Mln

Total Debt: $57.27 Mln

Insider's Holding: 11.52%

Liquidity: Low

52 Week range: $3.25 - 8.75

Shares outstanding: 41,241,400

10 Years Aggregate:

  • CFO: $45.14 Mln
  • EBITDA: $38.81 Mln
  • Net Profit: $-35.77 Mln

Stock Performance

Time Period Harvard Bioscience (HBIO) S&P BSE Sensex* S&P Small-Cap 600*
YTD-47.52-8.62-18.78
1 month-1.33-4.54-8.00
3 months-40.42-10.19-13.65
1 Year-55.581.43-17.19
3 Years22.7610.146.10
5 Years7.7311.265.87
10 Years6.4311.829.84
As on 01-Jul-2022 *As on 04-Jul-2022
Year Harvard Bioscience (HBIO) S&P Small-Cap 600 S&P BSE Sensex
202164.3425.2721.99
202040.669.5715.75
2019-4.0920.8614.38
2018-3.62-9.705.87
20178.2011.7327.91
2016-12.1024.741.95
2015-38.80-3.36-5.03